logo
15:50 Dec 05

Valiant Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
71.63
+7.06 (+10.93%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Valiant Laboratories Ltd. Financials

Valiant Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
71.63
+7.06 (+10.93%)
15:50 Dec 05
Quality
image/svg+xml

30/100
Low Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

28/100
Technically Bearish

Strength

4

Weakness

15

Opportunity

0

Threats

0

-0.93 %

ROE %

-0.54 %

ROA %

0.00

EPS

53.93

BVPS

-1.65 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
333.91 182.06 133.38 161.32
Operating Expenses +
298.83 190.46 138.06 161.23
Raw Material
277.56 169.39 112.74 133.18
Increase Decrease in Cost
-0.24 -1.14 3.86 4.08
Other Manufacturing Expense
0 0 0 0
Employee Cost
4.61 4.31 4.39 4.63
Miscellaneous Expenses
17.46 17.9 18.19 19.34
Operating Profit
35.08 -8.4 -4.68 0.09
Other Income
4.86 9.68 5.43 3.29
Depreciation
1.56 1.97 2.09 2.09
Interest
0.25 0.08 0.18 0.19
Profit before tax and exceptio..
38.14 -0.77 -1.51 1.1
Exceptional Items
0 0 0 0
PBT
38.14 -0.77 -1.51 1.1
Provision for Taxation
9.14 -1.09 0.69 0.97
Net Profit
29 0.32 -2.2 0.13
NET Profit after MI
29 0.32 -2.2 0.13
EPS
8.91 0.13 -0.51 0.03
Operating Profit Margin (%)
10.51 -4.61 -3.51 0.06
Net Profit Margin (%)
8.69 0.18 -1.65 0.08

Valiant Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: